The U.S. Supreme Court has denied certiorari from a U.S. Court of Appeals for the Third Circuit decision that private insurers that provide Medicare benefits have the right to recover, just as the federal government does, from GlaxoSmithKline for expenses incurred for injuries consumers have suffered by taking the drugmaker’s Avandia diabetes drug.
The Third Circuit is the first circuit court to determine that Medicare Advantage/Part C organizations, or private insurers that get paid by the government to provide Medicare benefits, have the same right as the government to make subrogation claims and assert liens in federal court against settlements plaintiffs receive, said Michael Russell, an attorney with lien administrator Garretson Resolution Group, headquartered in Cincinnati and Charlotte, N.C.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
